Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amiodarone for Prevention of AF Following Noncardiac Thoracic Surgery
NCT00127712Phase 4Completed
- Sponsor
- Indiana University
- Start
- Sep 2004
- Primary completion
- Feb 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of amiodarone in Atrial fibrillation (AFib) (2 arms), sponsored by Indiana University. Primary endpoints: Incidence of Atrial Fibrillation Requiring Treatment at 7 days and Incidence of Atrial Fibrillation Lasting Longer Than 30 Seconds at 7 days. Started Sep 2004; status: completed.
02
Drugs
amiodarone
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT00127712.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00127712.